Introduction
============

The fallopian tube epithelium (FTE) comprises two cell types, namely ciliated and secretory cells. Ciliated cells are responsible for sperm and egg transportation [@B1],[@B2]. Through producing fluid, secretory cells provide a microenvironment in which sperm and eggs can meet [@B3]. Fallopian tube epithelial cells (FTECs) have been thought to be the origin of high-grade serous ovarian carcinoma (HGSOC). Furthermore, the loss of P53 function was thought to be the necessary event for HGSOC initiation [@B4]. The fallopian tubes are located adjacent to the ovaries and are exposed to follicular fluid (FF) during ovulation each month [@B5]. FF contains numerous inflammatory factors, which can lead the epithelium to induce a double-strand break [@B6]. The accumulation of inflammatory factors (injuries) from repetitive ovulation may induce cancer and cell injuries.

However, because of people\'s reproductive needs, the regeneration of injured epitheliums is crucial. The presence of "stem cell-like" cells in the FTE has been postulated [@B7]-[@B9]. The Wnt and Notch signaling pathways are responsible for the continuous proliferation and differentiation of organoids [@B10]. Wnt/beta-catenin is one of the major signaling pathways maintaining pluripotency in stem cells [@B11],[@B12]. Frizzled receptors and LRP5/6 coreceptors bind to Wnt and inhibit beta-catenin degradation, thereby promoting cell-cycle progression and inhibiting apoptosis [@B13]. Dkk1 was able to block this signaling pathway through LRP6 coreceptor isolation [@B14]. In the intestines and ovaries [@B15], Wnt signaling could also act through R-spondin family proteins [@B16] and bind to Wnt target genes [@B17].

In the intestinal tract, skin, liver, and ovaries [@B10], stemness is maintained by active Wnt signaling and is centered on a subfamily of leucine-rich repeat-containing G protein-coupled receptors called Lgr4, Lgr5, and Lgr6 [@B10], which are Wnt target genes and have the capacity to greatly amplify Wnt signals; the R-spondin family of proteins acts as LGR receptor agonists [@B18].

Notch signaling is responsible for regulating genes of known stem cell factors [@B10]. Notch inhibitors decrease both Notch signaling and Wnt signaling as well as another stemness gene, olfactomedin 4 (OLFM4), in the FTE [@B10].

Estrogen is a steroid hormone and has an effect on multiple tissues, including the FTE. Estrogen can help the movement and maturation of eggs, sperm, and embryos in the fallopian tube [@B19]. Furthermore, it can send signals through three types of receptor, including estrogen receptor (ER) alpha, ER beta, and ER G protein-coupled receptors [@B20],[@B21]. Hormone therapy featuring estrogen was suggested to increase the incidence of ovarian cancer [@B22]. A relevant study showed that ER alpha was expressed in 80% of HGSOC tissues, and progesterone receptor (PR) was expressed in 30% of HGSOC tissues [@B23]. Another relevant study showed that the FTE of mice could respond to estrogen stimulation through regulating the expression of a tissue-specific set of target genes [@B24].

Both estrogen and progesterone have crucial effects on the antiapoptosis, proliferation, contraction, and cytokine production in the FTE [@B24]-[@B27]. A report indicated that progesterone could induce necroptosis in p53-defective FTECs and prevent the occurrence of HGSOC.

Nevertheless, the effect of hormones on the morphology and stemness genes of FTECs remains unknown. Thus, the aim of this study was to evaluate the effect of hormones on morphology changes and expression of genes in derived FTECs.

Materials and Methods
=====================

Derivation and culture of primary FTECs
---------------------------------------

The experimental protocol was approved by the Research Ethics Committee of Buddhist Tzu Chi General Hospital (IRB 104-70B). Surgical specimens of fallopian tubes were obtained from patients under bilateral salpingectomy accompanied by hysterectomy or other ovarian surgery. Only normal fallopian tubes uncontaminated with cancer cells were collected. For the culture of FTECs, we followed a previously published and modified protocol [@B7]. In brief, the FTE was separated from the underlying stroma, and then a small segment of fallopian tube was washed in 5 mM ethylenediaminetetraacetic acid (EDTA) and incubated in 1% trypsin for 45 min. Subsequently, the FTE was digested at 37°C for 45 min in 0.8 mg/mL of collagenase in Dulbecco\'s Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 5 μg/mL of insulin. Next, the FTE was incubated in prewarmed 0.05% trypsin-EDTA (Invitrogen, Grand Island, NY, United States). Then, the FTE was pierced five times for dissociation, and DMEM containing 10% FBS was added to stop the trypsinization. Finally, the resulting FTECs were placed on gelatin-coated wells.

Proliferation assay
-------------------

The FTECs were seeded in triplicate at a density of 2 × 10^3^ cells/cm^2^ in a 96-well plate with DMEM, 10 % FBS, and 5 μg/mL of insulin. The FTECs at passage 2 and 3 were used for a proliferation assay. Cells were harvested and counted using a cell proliferation kit (XTT based, Biological Industries Ltd., Kibbustz Beit Haemek, Israel) on days 0, 3, and 7, and a growth curve was generated. XTT solution and N-methyl dibenzo-pyrazine methyl sulfate (PMS) were defrosted immediately prior to use in a 37°C bath. PMS was added to the XTT solution immediately before use, and 50 μL of XTT/PMS was added to each 100-μL culture. After 2-5 h of incubation, the optical density of the wells was determined using a spectrophotometer (ELISA reader, BioTek, Winooski, VT, U.S.A) at a wavelength of 450 nm and a reference wavelength of 650 nm.

Flow cytometry of FTECs
-----------------------

Surface molecules of the FTEC cultures on passage 3 were characterized using flow cytometry. Three FTEC cell lines were enrolled for testing. Cells were detached using 2 mM EDTA in PBS, washed with PBS containing 2% bovine serum albumin and 0.1% sodium azide (Sigma, Saint Louis, MO, United States), and incubated with their respective antibody conjugated with fluorescein isothiocyanate (FITC) or phycoerythrin (PE). The FTE stem cell marker Lgr5 (GeneTex, Irvine, CA, United States) and the embryonic stem cell markers SSEA3 (eBioscience, ThermoFisher, Waltham, MA, USA) and SSEA4 (Abcam, Cambridge, England) were used for identification of the FTECs. Cells were analyzed using a flow cytometer (Becton Dickinson, San Jose, CA, United States).

Estrogen and progesterone treatment
-----------------------------------

Estradiol-17β (Sigma) was prepared as a stock solution at 1 mg/mL in absolute alcohol. This stock solution was diluted in culture medium to final concentrations of 200 and 400 nM to mimic FF estradiol levels [@B28], and progesterone (Sigma) was diluted in culture medium to a final concentration of 15 μM to mimic FF progesterone levels [@B29]. FTECs were treated with estradiol for 7 days and then fixed in paraformaldehyde for immunohistochemistry (IHC) staining.

Immunohistochemistry
--------------------

IHC was used to evaluate the expression of anti-PAX8 antibodies for secretory cells (1:50, Abcam), anti-TUBB4 for ciliated cells (1: 50, Abcam), and DAPI for a nucleus (1:200, GeneTex, Irvine CA, United States) in FTECs. The FTECs were fixed with 4% paraformaldehyde, permeabilized with 0.1% Triton X-100, blocked with 4% normal goat serum, and then treated with the abovementioned primary antibodies. The FTECs with antibody staining were analyzed using confocal laser scanning microscopy (LSM 510 META; Zeiss, Jena, Germany).

Scanning electron microscopy
----------------------------

FTECs cultured in culture medium with 0 and 400 nM estradiol for 14 days and grown on collagen inserts were fixed in 4% formaldehyde and 2.5% glutaraldehyde in phosphate buffer for 15 min. The membranes were dehydrated in a series of alcohols and critical-point dried. The mount membranes were coated in an SEM E5000 coating unit and examined using scanning electron microscope (H-7500; Hitachi, Tokyo, Japan). In an additional experiment, FTECs with a fibrillary appearance were quantified after estradiol treatment. First, 200 FTECs were placed in a single well of an eight-well chamber slide (Nunc, Rochester, New York, United States). After treatment with estradiol for 14 days, the FTECs were fixed and pictures were captured using a microscope. FTECs with fibrillary appearance were counted in each group (control, 200 nM E2, and 400 nM E2). Finally, the data were presented as the percentage of FTECs with fibrillary appearance.

Ribonucleic acid extraction and quantitation
--------------------------------------------

Total ribonucleic acid (RNA) was prepared from two endometrial cancer cell lines (Ishikawa and HEC1A) and five FTEC lines using TRIzol solution (Invitrogen). Next, 1 μg of DNase-treated RNA was transcribed into complementary DNA using 200 units of Superscript II reverse transcriptase (Invitrogen). The sequence of primers was ERα: forward: 5\'- CCACCAACCAGTGCACCATT-3\' and reverse: 5\'- GGTCTTTTCGTATCCCACCTTTC-3\'; ERβ: forward: 5\'- AGAGTCCCTGGTGTGAAGCAAG-3\' and reverse: 5\'- GACAGCGCAGAAGTGAGCATC-3\'; PR: forward: 5\'- CGCGCTCTACCCTGCACTC-3\' and reverse: 5\'- TGAATCCGGCCTCAGGTAGTT-3\'; and GAPDH: forward: 5\'- GGTCTCCTCTGACTTGAACA-3\' and reverse: 5\'- GTGAGGGTCTCTCTCTTCCT-3\'. All PCR samples were analyzed using electrophoresis on 2% agarose gel (Invitrogen) containing 0.5 μg/mL of ethidium bromide (Sigma-Aldrich).

Total RNA of FTECs at passage 3 with different treatments (control, 200 and 400 nM E2, and 15 μM progesterone) for 7 days was extracted using an RNEasy® kit (Qiagen, Valencia, CA, United States) according to the manufacturer\'s instructions. Real-time PCR analysis for stemness markers (OLFM4 \[forward: 5\'-A​C​T​G​T​C​C​G​A​A​T​T​G​A​C​A​T​C​A​T​G​G-3\'​ and reverse: 5\'-T​T​C​T​G​A​G​C​T​T​C​C​A​C​C​A​A​A​A​C​T​C-3\'​\] [@B30], AXIN2 \[forward: 5\'-C​C​T​G​C​C​A​C​C​A​A​G​A​C​C​T​A​C​A​T-3\'​ and reverse: 5\'-​T​T​C​A​T​T​C​A​A​G​G​T​G​G​G​G​A​G​A-3\'​\] [@B31], and LGR6 \[forward: 5\'-C​C​T​T​C​C​T​C​A​G​C​T​T​C​A​C​C​T​T​G-3\'​ and reverse: 5\'-C​T​T​C​C​A​G​G​C​C​T​T​T​C​T​C​T​G​T​G-3\'\] [@B32]); Notch signaling (Hes1 \[forward: 5\'-T​T​C​T​G​A​G​C​T​T​C​C​A​C​C​A​A​A​A​C​T​C-3\'​ and reverse: 5\'-A​G​G​C​G​C​A​A​T​C​C​A​A​T​A​T​G​A​A​C-3\'​\]) [@B33]; SSEA4 synthase (forward: 5\'-TGGACGGGCACAACTTCATC-3\' and reverse: 5\'-GGGCAGGTTCTTGGCACTCT-3\') [@B34]; b3GalT5 (forward: 5\'-GCAGATCTATGGCTTTCCCGAAGATG-3\' and reverse: 5\'-GTCTCGAGTCAGACAGGCGGACAAT-3\') [@B35]; Lgr5 (forward: 5\'-ACCCGCCAGTCTCCTACATC-3\' and reverse: 5\'-GCATCTAGGCGCAGGGATTG-3\') [@B36]; Aldh1 (forward: 5\'-CTGCTGGCGACAATGGAGT-3\' and reverse: 5\'-GTCAGCCCAACCTGCACAG-3\') [@B37] was performed. Complementary DNA was synthesized using a SuperScript III One-Step RT-PCR kit (Invitrogen, Grand Island, NY, United States) and amplified using PCR with an AmpliTaq Gold Kit (Applied Biosystems, Foster City, CA, United States). Real-time PCRs were performed and monitored using a FastStart Universal SYBR Green Master kit (Rox) (Roche, Indianapolis, IN, United States) and a quantitative real-time PCR detection system (ABI Step One Plus system; Applied Biosystems, Foster City, CA, United States). The gene products were analyzed with the *GAPDH* gene (forward: 5\'-TCT CCT CTG ACT TCA ACA GCG AC-3\' and reverse: 5\'-CCC TGT TGC TGT AGC CAA ATT C-3\') as a reference. The expression level of each target gene was then calculated as 2^-ΔΔCt^ as previously described [@B38]. Four readings of each experimental sample were obtained for each gene of interest, and the experiments were repeated at least in triplicate.

Statistical analysis
--------------------

The results were expressed as the mean ± standard deviation. Raw data were analyzed using the Student\'s *t*-test to compare CD markers between two passages. Additionally, the following tests were performed: analysis of variance (ANOVA), one-way ANOVA with repeated measures, post-hoc tests, and Fisher\'s least significant difference test for gene expression between four treatment groups, where a *p* \< 0.05 denoted statistical significance.

Results
=======

FTECs isolated from the epithelial layer grew to P9
---------------------------------------------------

We isolated FTECs from FTE sheets (Fig. [1](#F1){ref-type="fig"}A). The FTECs from P2 to P6 exhibited the same morphology and had a cobblestone appearance (Fig. [1](#F1){ref-type="fig"}B). The proliferation pattern of FTECs at P3 exhibited a normal cell growth pattern over 7 days (Fig. [1](#F1){ref-type="fig"}C).

FTECs expressed the stem cell markers Lgr5, SSEA3, and SSEA4
------------------------------------------------------------

The expression of stem cell markers in FTECs was investigated using flow cytometry. Three stem cell markers, Lgr5 (intestinal and fallopian tube stem cell marker) and SSEA3 and 4 (embryonic and cancer stem cell markers), were selected for evaluation. All three FTEC lines expressed these three stem cell markers at different percentages (Fig. [2](#F2){ref-type="fig"}). Two cell lines expressed less SSEA4. Isotype IgG was used as a negative control. These results indicated that the isolated FTECs could express various stem cell markers.

FTECs expressed hormone receptors
---------------------------------

To evaluate whether FTECs could express hormone receptors to received hormone treatment, RT-PCR was used to detect gene expression. The results showed that ERα, β, and PR were expressed by FTECs (Fig. [3](#F3){ref-type="fig"}).

Hormones did not alter FTECs\' morphology
-----------------------------------------

Hormones such as estradiol and progesterone have effects on the reproductive organs [@B25]. Therefore, estrogen and progesterone were added to the FTEC culture to investigate their effects on the cells. The cell culture was treated with 200 nM estradiol and 15 μM progesterone for 14 days. All FTECs stained positive for PAX8 and TUBB4 (Fig. [4](#F4){ref-type="fig"}). The results indicated no changes in PAX8 or TUBB4 expression and cell morphology after estradiol and progesterone treatment.

High concentration of estrogen caused fibrillary outgrowth of FTECs
-------------------------------------------------------------------

Because estrogen treatment could induce ciliated cell phenotypes [@B39], we explored the effects of a high concentration of estradiol on FTECs. The FTEC cells, which were grown on collagen inserts, exhibited a cobblestone appearance without villi (Fig. [5](#F5){ref-type="fig"}A and B). Nevertheless, scanning electron microscopy revealed fibrillary-like structures near the cell membrane after treatment with 400 nM estradiol (Fig. [5](#F5){ref-type="fig"}C and D). Subsequently, we quantitated the FTECs that had a fibrillary appearance after hormone treatment (Fig. [6](#F6){ref-type="fig"}), which revealed that in the hormone treatment group (400 nM E2) approximately 2% of cells had a fibrillary appearance. By contrast, only 0.5% of cells in the control group exhibited a fibrillary appearance (Fig. [6](#F6){ref-type="fig"}). Statistical analysis of the difference between the groups revealed a *p*-value of \<0.05. In summary, a high concentration of estradiol (400 nM) caused fibrillary outgrowth in FTECs.

Both estrogen and progesterone increased stemness gene expression in FTECs
--------------------------------------------------------------------------

The effect of hormones on FTECs was investigated using quantitative PCR for Wnt- and Notch-related stemness genes. The FTECs were treated with estrogen and progesterone for 7 days. All stemness genes related to the Wnt (OLFM4, AXIN2, and LGR6) and Notch (HES1) signaling pathways, ES cell markers (SSEA3 and SSEA4), Aldh1, and Lgr5 had significantly increased expression after progesterone treatment (Fig. [7](#F7){ref-type="fig"}). Taken together, after estradiol and progesterone treatment, stemness gene expression in FTECs was significantly increased.

Discussion
==========

In the present study, we successfully derived human FTECs, which were able to express estrogen and PRs. Estradiol treatment caused ciliated differentiation of the FTECs. Furthermore, treatment of FTECs with either estradiol or progesterone in culture medium increased stemness gene expression (both Wnt and Notch signaling pathways) compared with nontreated controls.

Because the fallopian tube is exposed to cyclical hormone changes, mechanisms to ensure its long-term renewal and integrity are critical. In addition, estrogen and progesterone have crucial effects on the antiapoptosis, proliferation, contraction, and cytokine production of the FTE [@B24]-[@B27]. The fallopian tube could express ERβ and PRs [@B40],[@B41]. A relevant study showed that after 150 ng/mL of estradiol treatment, FTE cells could differentiate into ciliated cells [@B39]. In the present study, we demonstrated that hormones did not influence the cells\' gross morphology. However, after 7 days of exposure to a high concentration of estrogen (400 nM), a fibrillary-like structure near the cell membrane was noted. This indicated that FTECs could differentiate into ciliated cells under estrogen stimulation.

The effects of Wnt inhibition indicated a crucial role of the Wnt pathway in stemness regulation in FTECs. In one study, Notch signaling-related genes were overlapped between human fallopian tubes and mouse intestines [@B36], which indicated that both may have similar regulatory mechanisms. Lgr5-expressing intestinal cells exhibited a stem cell niche. In our study, after progesterone treatment, Lgr5 expression in FTECs was also increased. Another LGR subfamily, Lgr6, exhibited increased expression after progesterone treatment. These two LGR subfamilies could be the receptor of another crucial factor, R-spondin-1, which regulates the self-renewal of fallopian tube stem cells through Wnt signaling. As reported in both humans and mice, Lgr5 was expressed in ovarian surface epithelial cells but not in FTECs, whereas Lgr6 was expressed in FTECs. Nevertheless, Lgr5 expression was detected at quite high levels in the present study. This phenomenon may be caused by a two-dimensional tissue culture condition.

Studies have shown that OLFM4 is a highly specific marker for intestinal stem cells [@B42] and colorectal cancer [@B43]. OLFM4 deletion induced colon cancer [@B44]. In another study, the inhibition of OLFM4 inhibited tumorigenicity [@B45]. In our study, we found that OLFM4 exhibited increased expression following progesterone treatment. This indicated that after ovulation, progesterone might increase stemness gene expression in FTECs.

Wnt and Notch signaling are crucial for the organoid growth and differentiation of FTECs [@B10]. AXIN2 and LGR6 expression are related to the Wnt signaling pathway. A relevant study indicated that AXIN2 inhibition was correlated with type 1 pneumocyte differentiation from type 2 progenitor cells [@B46]. AXIN2 can respond to tooth damage and regenerate odontoblasts [@B47]. In our study, both 200 nM estradiol and 200 nM progesterone could increase AXIN2 expression in FTECs, which may indicate that during the menstrual cycle, the AXIN2 expression of FTECs can be a response to stimulation by both hormones.

SSEA3 and SSEA4 are known as embryonic stem cell markers [@B34],[@B35], and both are known as cancer stem cell markers [@B35],[@B48]. In our study, FTECs could express SSEA3 and SSEA4. After hormone treatment, expression of both markers was increased in FTECs.

Aldh1 is a known cancer stem cell marker and is correlated with prognosis [@B49]. Aldh1 is also responsible for enhanced invasiveness and the endothelial-mesenchymal transition process [@B50]. In our study, after progesterone treatment, Aldh1 expression was increased in FTECs.

In our study, estrogen and progesterone could increase stemness gene expression (Wnt and Notch signaling pathways). In general, less stemness gene expression was noted in the groups treated with 400 nM E2 compared with those treated with 200 nM. A study showed that a high concentration of E2 may downregulate ER and cause decreased gene expression [@B51]. Moreover, after progesterone treatment, stemness gene expression increased compared with the control and E2-treated groups. Another study indicated that progesterone is often considered an antagonist in modulating the effects of estrogen in the fallopian tubes [@B52]. In our study, stemness markers increased simultaneously after estrogen or progesterone treatment. We speculated that in the luteal phase, both estrogen and progesterone could be maintained at high concentrations to prepare a suitable environment for embryo implantation. In addition to cilia cells, secretory cells are also involved in the development of tubal secretion. Thus, we observed that stemness markers increased after estrogen and progesterone treatment.

In conclusion, we successfully derived FTECs and evaluated hormone-related changes. Increased stemness gene expression upon hormone treatment was noted. The cells derived in this study may provide new insights into how FTECs regenerate and respond to hormones.
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![**Morphology and growth kinetics of fallopian tube epithelial cells (FTECs).** (A) The epithelial layer of a fallopian tube after manual extraction and isolation. (B) After dissociation and culturing, FTECs exhibited polygonal morphology; scale bar = 100 µm. (C) After culturing for 7 days, the growth kinetics of FTECs were evaluated using XTT assay on days 3 and 7. O.D. = optical density.](jcav10p3028g001){#F1}

![**Flow cytometry analysis of the expression of stem cell markers in fallopian tube epithelial cells (FTECs).** Flow cytometry of Lgr5, SSEA3, and SSEA4 of three FTEC cell lines (passage 3) are illustrated. FTEC expressed all three stem cell markers with different percentages. IgG was used as a negative control.](jcav10p3028g002){#F2}

![**Fallopian tube epithelial cells (FTECs) could express hormone receptor genes.** (A) Real-time polymerase chain reaction revealed that all FTEC cell lines (1-5) expressed estrogen receptor (ER) β and progesterone receptor (PR), and some expressed ERα. Endometrial cancer cells (Ishikawa and HEC1A cell lines) were used as positive controls. M: marker of base-pair numbers.](jcav10p3028g003){#F3}

![**Estradiol and progesterone treatments had no effect on the morphology of fallopian tube epithelial cells (FTECs).** Both 0 nM and 200 nM estradiol (E2) and 15 μM progesterone (P4) had no effect on cell morphology. PAX8: a secretory cell marker; TUBB4: a ciliated cell marker. Scale bar = 20 μm.](jcav10p3028g004){#F4}

![**Scanning electron micrograph of human fallopian tube epithelial cells (FTECs).** FTECs grown on gelatin collagen inserts for 14 days in culture medium without (A, B) or with (C, D) 400 nM estradiol (E2). The FTECs exhibited fibrillary-like structures near the cell membranes after treatment with 400 nM E2 (C, D). Scale = 100 μm in (A, C), 10 μm in (B, D).](jcav10p3028g005){#F5}

![**Quantification of fallopian tube epithelial cell (FTEC)-differentiated ciliated cells after hormone treatment**. (A) Gross picture of the FTECs in the control group. (B) FTECs after treatment with 200 nM estradiol (E2). (C) FTECs after treatment with 400 nM E2. (D) Quantification of hormone-treated FTECs with fibrillary appearance among groups. Scale bar = 100 μm. \**p* \< 0.05.](jcav10p3028g006){#F6}

![**Quantitative mRNA expression of fallopian tube epithelial cells (FTECs) after hormone treatment.** Passage 3 FTECs after 15 μM progesterone treatment for 7 days increased stemness markers (OLFM4, AXIN2, and LGR6), Notch signaling (Hes1), and stem cell markers (SSEA3, SSEA4, Aldh1, and Lgr5). The FTECs after 200 nM estradiol treatment also increased stemness markers (AXIN2, Hes1, SSEA4, Lgr5, and PAX8). \**p* \< 0.05, \*\**p* \< 0.001 compared with the controls. E2: estradiol. R.Q.: relative quantification to GAPDH.](jcav10p3028g007){#F7}
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